We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




BioSensor Quickly Identifies Bacteria and Bioagents

By HospiMedica staff writers
Posted on 21 Jul 2003
A powerful new biosensor can identify deadly bacteria, viruses that cause serious illness, agricultural pathogens, and biowarfare agents such as anthrax in a few minutes. More...
The development of the sensor was reported in the July 11, 2003, issue of Science.

Called Canary (cellular analysis and notification of antigen risks and yields), the sensor was developed by researchers at the Lincoln Laboratory of the Massachusetts Institute of Technology (Lexington, MA, USA). They created a special strain of mouse B lymphocyte cells and identified a jellyfish gene that allows the organism to produce a protein that glows. Then they genetically engineered B cell lines that glowed in response to specific bacteria and viruses.

The researchers generated B lymphocytes carrying the calcium-sensitive bioluminescent protein as well as antibodies for one or more pathogens. When the cells connect with the right pathogens, their calcium levels rise within seconds and they emit light. The cells are kept in a container that keeps them alive in a test tube and monitors their luminescence in the presence of pathogens. A laptop computer provides a readout of their response. Cell lines were created to detect a variety of pathogens, including anthrax, plague, smallpox, equine encephalitis, and chlamydia. Canary was able to detect as few as 50 colony-forming units of the plague bacterium in less than three minutes. Existing sensors based on chemical reactions can take several hours to provide results.

"Nature had already designed B cells to detect any bacteria and viruses very rapidly, so rather than come up with an artificial assay, I decided to go with what nature had already created,” said Todd H. Rider, a Senior Scientist of the Biosensor and Molecular Technologies Group at Lincoln Lab, who developed the sensor along with colleagues.




Related Links:
Massachusetts Institute of Technology

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Medical Monitor
SILENIO D
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.